Martin Claude, Cortegiani Andrea, Gregoretti Cesare, Martin-Loeches Ignacio, Ichai Carole, Leone Marc, Marx Gernot, Einav Sharon
Department of Anesthesia, Intensive Care and Trauma Center, Nord University Hospital, Aix Marseille University, APHM, Marseille, France.
Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.). Section of Anesthesia, Analgesia, Intensive Care and Emergency. Policlinico Paolo Giaccone. University of Palermo, Via del vespro 129, 90127, Palermo, Italy.
BMC Anesthesiol. 2018 Dec 22;18(1):200. doi: 10.1186/s12871-018-0669-3.
Fluids are by far the most commonly administered intravenous treatment in patient care. During critical illness, fluids are widely administered to maintain or increase cardiac output, thereby relieving overt tissue hypoperfusion and hypoxia.
Until recently, because of their excellent safety profile, fluids were not considered "medications". However, it is now understood that intravenous fluid should be viewed as drugs. They affect the cardiovascular, renal, gastrointestinal and immune systems. Fluid administration should therefore always be accompanied by careful consideration of the risk/benefit ratio, not only of the additional volume being administered but also of the effect of its composition on the physiology of the patient. Apart from the need to constantly assess fluid responsiveness, it is also important to periodically reconsider the type of fluid being administered and the evidence regarding the relationship between specific disease states and different fluid solutions.
The current review presents the state of the art regarding fluid solutions and presents the existing evidence on routine fluid management of critically ill patients in specific clinical settings (sepsis, Adult Respiratory Distress Syndrome, major abdominal surgery, acute kidney injury and trauma).
到目前为止,液体是患者护理中最常用的静脉治疗手段。在危重病期间,广泛使用液体以维持或增加心输出量,从而缓解明显的组织灌注不足和缺氧。
直到最近,由于其出色的安全性,液体未被视为“药物”。然而,现在人们明白静脉输液应被视为药物。它们会影响心血管、肾脏、胃肠道和免疫系统。因此,在给予液体时,始终应仔细考虑风险/效益比,不仅要考虑所给予的额外容量,还要考虑其成分对患者生理的影响。除了需要不断评估液体反应性外,定期重新考虑所给予液体的类型以及关于特定疾病状态与不同液体溶液之间关系的证据也很重要。
本综述介绍了液体溶液的最新情况,并展示了在特定临床环境(脓毒症、成人呼吸窘迫综合征、腹部大手术、急性肾损伤和创伤)中危重病患者常规液体管理的现有证据。